USPSTF Finds Little To Recommend In EBCT, Treadmill, ECG Coronary Scans
This article was originally published in The Gray Sheet
Executive Summary
Routine screening for coronary heart disease in patients at low risk for CHD-related events does not provide sufficient benefit to justify the prospect of false positives, the U.S. Preventative Services Task Force concludes in a Feb. 16 1recommendation statement
You may also be interested in...
ACC/AHA EBT Findings Based On Inappropriate Comparison - Imatron, SAI
Imatron Inc. is critical of research methods the American College of Cardiology and the American Heart Association used to compile an expert consensus document concluding that electron beam computed tomography demonstrates roughly 70% accuracy in predicting cardiac conditions in symptomatic patients.
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.
Quotable: Words Of Wisdom From Our Recent APAC Coverage
Scrip's APAC team selects notable quotes from recent interviews, conferences and other coverage to highlight the views of senior executives and officials on the major topics facing the biopharma sector in the region.